coronavirus

Lateral flow tests for COVID-19 can be very accurate and specific when used as directed, but introducing acidic fluids can cause the tests’ detecting antibodies to clump, which may read as a positive result.

SARS-CoV-2 infection triggers structural changes in the host cell’s DNA, which provide a molecular explanation for long COVID, a new study suggests. 

Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.

Researchers dissect the Neanderthal-derived region on chromosome 3 that drives severe COVID-19 to zero in on the key causal variants.

Warm nasal cells mount stronger defenses against cold-causing coronaviruses and rhinoviruses than those exposed to cooler temperatures, an in vitro experiment finds.

A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.

In flies and mice, a viral protein increases the rate of energy use by heart cells. But it’s not yet clear if the finding applies to humans.

Natural science research projects were among those promised funding by the now-collapsed crypto exchange’s “effective altruism” foundations.

The National Institute of Allergy and Infectious Diseases was not aware that the work involved a chimeric strain of SARS-CoV-2, STAT reports.

Low booster rates and immune-evading SARS-CoV-2 variants could spell bad news, experts say. 

Researchers say they’re abandoning the project in its current form—one of several that aims to induce what’s known as mucosal immunity against SARS-CoV-2.

Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  

A unique system measures multiple antigens simultaneously for vaccine development and beyond.

The results from two large clinical trials don't support the idea that supplements of the vitamin bolster immune defenses against SARS-CoV-2.

Launched with a $172 million philanthropic donation and funds from the state of Victoria, the Melbourne-based research institute aims to construct drug discovery platforms to speed the introduction of new therapies.

The immunizations are designed to target the latest Omicron subvariants, and are only authorized for people who have already received their primary vaccinations.

The Scientist spoke with Maximilien Chaumon about his database showing how COVID-19 related lockdowns warped more 2,800 people’s perception of time.

To understand the mechanisms behind severe COVID-19, researchers identified common COVID-19 genetic risk variants that affect immune cell function.

The 81-year-old director says that he will step back from his positions this December, but that he will continue working to advance science and public health.